GRC Report Staff

SEC Cracks Down on First Horizon for Regulation Best Interest Violations

The Securities and Exchange Commission (SEC) has taken action against First Horizon Advisors, Inc., a registered broker-dealer, for failing to comply with Regulation Best Interest (Reg BI). The charges, announced on September 18, 2024, specifically relate to First Horizon's recommendations of structured notes, a type of complex derivative security.

OCC and FDIC Align on Bank Merger Policies, Signaling New Era of Regulatory Transparency

The Office of the Comptroller of the Currency (OCC) and the Federal Deposit Insurance Corporation (FDIC) have both issued new policy statements on bank merger transactions. This aligned approach, announced on September 17, 2024, aims to bring unprecedented transparency and clarity to the bank merger review process.

Walgreens to Pay $106.8 Million in Major Healthcare Fraud Settlement

Retail pharmacy giant Walgreens has agreed to pay $106.8 million to settle allegations of widespread fraud against government health care programs, the U.S. Department of Justice announced on Friday. The settlement resolves claims that Walgreens billed Medicare, Medicaid, and other federal health care programs for prescriptions that were never actually dispensed to patients.

SEC Cracks Down on Investment Managers for Reporting Failures

The Securities and Exchange Commission (SEC) has nabbed 11 heavyweight investment managers for playing fast and loose with crucial reporting rules. The September 17 sting operation exposed a web of violations that's costing most of these financial juggernauts millions in penalties.

Municipal Advisory Firms Hit with $1.3 Million in Fines for Communication Blunders

The Securities and Exchange Commission (SEC) has taken aim at 12 municipal advisory firms, exposing a widespread failure to properly maintain crucial electronic communications. The firms, ranging from industry giants to smaller players, now face a collective $1.3 million in penalties for their oversight.

SEC Imposes $30 Million Penalty on Zymergen Inc. for Misleading IPO Investors

The U.S. Securities and Exchange Commission (SEC) has charged Zymergen Inc., a bankrupt biotechnology company based in Emeryville, California, with misleading investors during its initial public offering (IPO) in April 2021. The SEC announced the settled charges on September 13, 2024, highlighting serious misrepresentations about the company's market potential, revenue prospects, and customer pipeline for its primary product, Hyaline.

IIA Global Study Unveils Critical Trends Shaping the Future of Internal Auditing

The Institute of Internal Auditors (IIA) has released a report that sheds light on the future of the internal audit profession. Titled "Internal Audit: Vision 2035 – Creating Our Future Together," the study draws insights from over 7,000 practitioners and stakeholders worldwide, revealing key trends and challenges that will shape the profession over the next decade.